라우르산

Lauric Acid

HCID 3893CAS 143-07-7

기본 정보

표준 SMILES
CCCCCCCCCCCC(=O)O
InChIKey
POULHZVOKOAJMA-UHFFFAOYSA-N
분자식
C12H24O2
평균 분자량
200.32 g/mol
단동위원소 질량
200.17763001

개요

Lauric acid is a white solid with a slight odor of bay oil. (USCG, 1999)

이름 및 식별자

우선 이름
Lauric Acid
IUPAC
dodecanoic acid
현지명
라우르산
영어명
Lauric acid
분자식
C12H24O2
분자량
200.32

이름 및 동의어

lauric acidDODECANOIC ACID143-07-7n-Dodecanoic acidDodecylic acidLaurostearic acidVulvic acidDodecoic acidDuodecylic acid1-Undecanecarboxylic acidAliphat No. 4Ninol AA62 Extra
이름 더 보기
라우르산도데카노익산라우릭산라우릭애씨드도데칸산1-운데케인카복실산n-도데칸산데다콘산도데실산도데칸 산도데코 산도데크산듀오-디시클릭 산라우로스테아르 산로로스테아르산로르산하이드로폴 산 1255C12Emery651FEMA 2614Fatty acid methyl ester sulfonate (MES)dodecanoic acid (lauric acid)
Wecoline 1295Hydrofol acid 1255Hydrofol acid 1295Univol U-314Duodecyclic acidHystrene 9512Lauric acid, pureLaurinsaeure

데이터베이스 식별자

CAS
143-07-7、203714-07-2、7632-48-6、8000-62-2、8045-27-0
PubChem CID
3893
DTXSID
DTXSID5021590
ChEBI
CHEBI:30805
UNII
1160N9NU9U
EC Number
205-582-1、606-539-3、616-324-6、616-778-5、617-074-0
Nikkaji
J2.548H

물성

구조 계산 물성

XLogP
4.2
극성 표면적
37.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
2
회전 가능 결합 수
10
무거운 원자 수
14

실험 및 물리화학적 성질

Chemical ClassesOther Classes -> Organic Acids
DrugsPharmaceuticals -> Listed in ZINC15
Lipids · 2건

Lipids -> Unambiguous Lipids

Fatty Acyls [FA] -> Fatty Acids and Conjugates [FA01] -> Straight chain fatty acids [FA0101]

Polymers · 2건

Plastics -> Other functions -> Emulsifier

Plastics -> Polyolefin-I; Polyolefin-II

Cosmetics · 2건

Cosmetic ingredients (Lauric Acid) -> CIR (Cosmetic Ingredient Review)

Surfactant; Emulsifying; Cleansing

SpringerMaterials PropertiesBoiling point

물리화학적 성질

녹는점
44 · 44-46 °C (lit.)
끓는 점
225 °C/100 · 225 °C/100 mmHg (lit.)
밀도
0.883 g/mL · 0.883 g/mL at 25 °C (lit.)
증기압
1 mm · 1 mm Hg ( 121 °C)
굴절률
1.4304 · 1.4304
FEMA
2614 · 2614 | LAURIC ACID
화학적 성질 · 1건

Like many other fatty acids, lauric acid is inexpensive, has a long shelf-life, and is non-toxic and safe to handle. It is mainly used for the production of soaps and cosmetics. For these purposes, lauric acid is neutralized with sodium hydroxide to give sodium laurate, which is a soap. Most commonly, sodium laurate is obtained by saponification of various oils, such as coconut oil. These precursors give mixtures of sodium laurate and other soaps.

안전 및 규제

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 1.5% (38 of 2566) of reports.

Danger

H315 (13.3%): Causes skin irritation [Warning Skin corrosion/irritation]

P264, P264+P265, P280, P302+P352, P305+P351+P338, P305+P354+P338, P317, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)

Aggregated GHS information provided per 2566 reports by companies from 24 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 5건

Chemical: Dodecanoic acid

Dodecanoic acid is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Dodecanoic acid are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

2008/127, Reg. (EU) 2017/195, Reg. (EU) 2020/1160, Reg. (EU) 2023/1446, Reg. (EU) 2024/1280, Reg. (EU) 2024/2221, Reg. (EU) No 540/2011

Status: Active Update: 19-04-2023 https://echa.europa.eu/registration-dossier/-/registered-dossier/15262

Dodecanoic acid: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Dodecanoic acid: Human health tier I assessment
Fire HazardsBehavior in Fire: May cause dust explosion. (USCG, 1999)
Fire Potential · 2건

Combustible when exposed to heat or flame.

Combustible

Health HazardsMay be harmful by inhalation, ingestion or skin absorption. Vapor or mist is irritating to eyes, mucous membrane and upper respiratory tract. Causes eye and skin irritation. (USCG, 1999)
Hazards SummaryA skin, eye, and respiratory tract irritant; [CAMEO] MAK-3A (Could be carcinogenic for man but not conclusive because of insufficient data); [MAK] A mild irritant; [MSDSonline]

안전 및 보호

Fire FightingFire Extinguishing Agents: Carbon dioxide, dry chemical, alcohol foam, water spray. (USCG, 1999)
First Aid · 1건

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Exposure Control and Personal Protection2.0 [mg/m3], inhalable fraction, (can also occur as vapor and aerosol)[German Research Foundation (DFG)]
Nonfire Spill ResponseNeutralizing Agents for Acids and Caustics: Sodium bicarbonate solution; flush with water. (USCG, 1999)
Disposal Methods · 4건

SRP: The most favorable course of action is to use an alternative chemical product with less inherent propensity for occupational exposure or environmental contamination. Recycle any unused portion of the material for its approved use or return it to the manufacturer or supplier. Ultimate disposal of the chemical must consider: the material's impact on air quality; potential migration in soil or water; effects on animal, aquatic, and plant life; and conformance with environmental and public health regulations.

The following wastewater treatment technology has been investigated for lauric acid: Concentration process: Biological treatment.

The following wastewater treatment technology has been investigated for lauric acid: Concentration process: Activated carbon.

The following wastewater treatment technology has been investigated for lauric acid: Concentration process: Resin adsorption.

Preventive Measures · 1건

SRP: The scientific literature for the use of contact lenses in industry is conflicting. The benefit or detrimental effects of wearing contact lenses depend not only upon the substance, but also on factors including the form of the substance, characteristics and duration of the exposure, the uses of other eye protection equipment, and the hygiene of the lenses. However, there may be individual substances whose irritating or corrosive properties are such that the wearing of contact lenses would be harmful to the eye. In those specific cases, contact lenses should not be worn. In any event, the usual eye protection equipment should be worn even when contact lenses are in place.

독성 정보

Interactions · 5건

...the effect of lauric acid on transdermal penetration of phenazepam /was studied/ in vivo. It was found that treatment with lauric acid 3-fold increased the maximum anticonvulsive effect of phenazepam applied in a transdermal therapeutic system in comparison with the control. Study of the pharmacokinetics of phenazepam transdermal therapeutic system showed its higher bioavailability in the presence of lauric acid (f=0.9).

The effect of two fatty acids, oleic acid and lauric acid (dodecanoic acid), on the transport of the cationic drug naphazoline, neutral caffeine, and anionic sodium salicylate, across excised human skin was studied using Franz diffusion cells. Both acids increased the in vitro skin permeation of all penetrants. Oil/water partitioning data and rotating diffusion cell measurements, in the presence of the fatty acids, suggested that the enhanced flux of the cationic naphazoline could be accounted for by an increase in lipophilicity through ion pairing with the carboxylate anion of the acid. Both neutral caffeine and sodium salicylate were incapable of forming ion pairs; consequently, increases in skin permeability are also due to a disruption of the stratum corneum. This conclusion was further supported by increased transepidermal water loss, and increased in vivo skin permeation of the non ion-pairing methyl nicotinate at skin sites treated with the fatty acids.

The transdermal absorption of bupranolol was studied in vitro using a model membrane and human skin samples; the effects of oleic acid and dodecanoic acid (lauric acid) on bupranololabsorption were also evaluated. Bupranolol diffused through skin samples rapidly. The transfer of bupranolol across the model membrane was enhanced in the presence of oleic acid and dodecanoic acid. They did not, however, significantly enhance the transfer across human skin samples.

Cytochromes P450IVA1 and IVA3 display 72% amino acid sequence similarity and are expressed in livers of rats treated with the hypolipidemic drug clofibrate. The catalytic activities of IVA1 and IVA3 were examined by cDNA-directed expression using vaccinia virus. cDNA-expressed IVA1 and IVA3 had relative Mrs of 51,500 and 52,000, respectively, on SDS-polyacrylamide gels. Both enzymes displayed reduced, CO-bound absorption spectra with lambda max of 452.5 nm. IVA1 and IVA3 hydroxylated lauric acid at the omega and omega-1 positions with equivalent omega/omega-1 ratios of about 12.5. IVA1 had a substrate turnover of 21/min which was about fourfold higher than that of IVA3. The omega and omega-1 hydroxylation of palmitic acid was also catalyzed by these P450s with combined turnover numbers for both metabolites of 45/min or 18/min for IVA1 and IVA3, respectively. The omega/omega-1 oxidation ratio of IVA1 for palmitate was 1.25 which was almost fourfold higher than that obtained for IVA3. These enzymes also catalyzed omega oxidation of the physiologically important eicosanoids prostaglandins E1 and F2 alpha with turnover numbers of about one-tenth those calculated for fatty acid oxidations. No omega-1 hydroxy metabolites were produced. These studies indicate that the P450 enzymes IVA1 and IVA3 are able to catalyze the oxidations of both fatty acids and prostaglandins.

The influence of ciprofibrate, a potent oxyisobutyrate derivative, on several hepatic enzyme parameters was studied in five rat strains following a 14 day treatment period. Ciprofibrate dependent hepatomegaly was observed at two dose levels (2 and 20 mg/kg) in all rat strains examined. A 10 to 15-fold induction in the 12-hydroxylation of lauric acid with a less marked 1.5 to 5-fold induction of 11-hydroxylation was observed in treated animals. This dose-dependent increase in fatty acid hydroxylase activity was associated with a maximal 10-fold increase in the specific content of cytochrome p-450 IVA1 isoenzyme apoprotein, as assessed immunochemically using an ELISA technique. The activities of the cytochrome p-450 I (IA1 and IA2) and II (IIB1 and IIB2) families, as measured by ethoxyresorufin-O-deethylase and benzphetamine-N-demethylase activities respectively, were decreased on treatment. In the mitochondria, monoamine oxidase activity was significantly decreased at the higher dose level whereas alpha-glycerophosphate dehydrogenase activity was elevated. Total carnitine acetyltransferase activity (mitochondrial and peroxisomal) and peroxisomal beta-oxidation were markedly increased at both dose levels in all strains examined. Cytosolic glutathione peroxidase activity, measured using both t-butylhydroperoxide and hydrogen peroxide as substrates, was decreased on treatment to approximately 50% of the control value. In treated animals, a marked increase in mRNA levels coding for cytochrome p-450 IVA1 and the peroxisomal bifunctional protein of the fatty acid beta-oxidation spiral was observed. However, mRNA levels coding for glutathione peroxidase appeared unchanged following ciprofibrate administration, in contrast to the above-noted decrease of glutathione peroxidase enzyme activity. Taken collectively, our results have further substantiated a close association between the induction of microsomal cytochrome p-450 IVA1, peroxisomal beta-oxidation and total carnitine acetyltransferase activity in rat liver, and have performed a conceptual basis for the rationalization of the chronic toxicity of peroxisome proliferators in this species.

Ecotoxicity Values · 5건

EC50; Species: Xenopus laevis (African clawed frog, embryo); Conditions: freshwater, renewal, pH 7.0-7.8; Concentration: 21300 ug/L for 96 hr (20000-23000 ug/L); Effect: increased developmental changes, general (craniofacial defects, abnormal gut coiling) /> or =98% purity/

LC50; Species: Xenopus laevis (African clawed frog, embryo); Conditions: freshwater, renewal, pH 7.0-7.8; Concentration: 32100 ug/L for 96 hr (31000-33000 ug/L) /> or =98% purity/

EC50; Species: Daphnia magna (Water flea, age <24 hr); Conditions: freshwater, static; Concentration: 16900 ug/L for 48 hr (13000-22000 ug/L); Effect: intoxication, immobilization

LC50; Species: Lepomis macrochirus (Bluegill); Conditions: freshwater, static; Concentration: 35000 ug/L for 96 hr (25000-50000 ug/L)

For more Ecotoxicity Values (Complete) data for DODECANOIC ACID (8 total), please visit the HSDB record page.

Environmental Fate · 3건

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 7,600 for the free acid(SRC), determined from a log Kow of 4.60(2) and a regression-derived equation(3), indicates that undissociated dodecanoic acid is expected to be immobile in soil(SRC). The pKa of dodecanoic acid is 5.3(4), indicating that this compound will exist almost entirely in anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization of dodecanoic acid from moist soil surfaces is not expected to be an important fate process(SRC) based on the pKa. Dodecanoic acid is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.6X10-5 mm Hg(6). Dodecanoic acid had a one-day theoretical BOD of 6.1% in a Warburg respirometer using activated sludge inocula(7), and a 100% TOC reduction in activated sludge within 100 hrs(8), suggesting biodegradation of dodecanoic acid an important environmental fate(SRC).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 7,600 for the free acid(SRC), determined from a log Kow of 4.60(2) and a regression-derived equation(3), indicates that undissociated dodecanoic acid is expected to adsorb to suspended solids and sediment(SRC). A pKa of 5.30(4) indicates dodecanoic acid will exist almost entirely in the anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(5). According to a classification scheme(6), a BCF of 255 in zebrafish (Danio rerio)(7), suggests bioconcentration in aquatic organisms is high, provided the compound is not metabolized by the organism(SRC). Dodecanoic acid had a one-day theoretical BOD of 6.1% in a Warburg respirometer using activated sludge inocula(8), and a 100% TOC reduction in activated sludge within 100 hrs(9), suggesting biodegradation of dodecanoic acid is an important environmental fate process in water(SRC).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), dodecanoic acid, which has a vapor pressure of 1.6X10-5 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase dodecanoic acid is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 27 hours(SRC), calculated from its rate constant of 1.4X10-11 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase dodecanoic acid may be removed from the air by wet or dry deposition(SRC). Dodecanoic acid does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(4).

Food Survey Values · 1건

Dodecanoic acid was found to be a volatile constituent of strawberries at a concn of 4.1 mg/kg and strawberry jam at a concn of 5.8 mg/kg(1). Dodecanoic acid is a constituent of mandarin oil(2) and coconut oil(3). Dodecanoic acid has been identified in mutton and beef volatiles(4). Dodecanoic acid was found in paprika oleoresin at <0.1 mg/kg(5). Dodecanoic acid was identified in raw beef using supercritical carbon dioxide extraction; 0.06% of the volatile fraction area was identified as dodecanoic acid(6). Dodecanoic acid was identified in roasted Chinese chestnuts (Castanea molissima)(7).

Toxicity Summary · 2건

The CIR Expert Panel concluded that the following ingredients are safe in the present practices of use andconcentration described in the safety assessment when formulated to be non-irritating and non-sensitizing, which may be basedon a QRA...Lauric Acid...

Safe for use in cosmetics, with qualifications

Average Daily Intake · 2건

Fatty acids are an important part of the normal daily diet of mammals, birds and invertebrates.

Annual consumption is 23,833.33 lb. Individual consumption is 0.02019 mg/kg/day.

규제 정보

FDA Requirements · 1건

Lauric acid is a food additive permitted for direct addition to food for human consumption, as long as 1) the quantity of the substance added to food does not exceed the amount reasonably required to accomplish its intended physical, nutritive, or other technical effect in food, and 2) any substance intended for use in or on food is of appropriate food grade and is prepared and handled as a food ingredient.

FIFRA RequirementsThe following inert ingredient is also eligible for inclusion in FIFRA Section 25(b) pesticide products applied to food use sites (e.g., food crops, animals used for food, etc.): lauric acid.

안전 데이터

wgk
1
tsca
TSCA listed
rtecs
OE9800000
독성
LD50 i.v. in mice: 131 ±5.7 mg/kg (Or, Wretlind)
HS 번호
29159010
risk_code
36/38-41-36/37/38

화학 및 산업

약리 정보

Mechanism of Action · 1건

It has been shown that polyunsaturated fatty acids such as arachidonic and docosahexanoic acids but not monounsaturated and saturated long-chain fatty acids promote basal and nerve growth factor (NGF)-induced neurite extension of PC12 cells, a line derived from a rat pheochromocytoma. On the other hand, short-chain fatty acids and valproic acid (2-propylpentanoic acid) enhance the growth of neurite processes of the cells only in the presence of inducers. In this study, we demonstrated that straight medium-chain fatty acids (MCFAs) at millimolar concentrations alone potently induced neuronal differentiation of PC12 cells. Hexanoic, heptanoic and octanoic acids dose-dependently induced neurite outgrowth of the cells: their maximal effects determined 2 days after addition to the culture medium were more marked than the effect of NGF. PC12 cells exposed to octanoic acid expressed increased levels of the neuronal marker beta-tubulin isotype III. Nonanoic, decanoic, and dodecanoic acids also induced growth of neurite processes, but their maximal effects were less marked than that of octanoic acid. In contrast, the polyunsaturated fatty acid linoleic acid and short-chain fatty acids had only slight or almost no effects on neurite formation in the absence of NGF. The effect of octanoic acid was synergistic with or additive to the effects of NGF and dibutyryl cyclic AMP. Octanoic acid upregulated phosphorylation of p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK), critical signaling molecules in neuronal differentiation, but not phosphorylation of Akt, a signaling molecule downstream of phosphatidylinositol 3-kinase (PI3K). Moreover, growth of neurites induced by octanoic acid was potently inhibited by treatment of cells with the p38 MAPK inhibitor SB203580 and the ERK kinase inhibitor PD98059 but not inhibited and only slightly inhibited by the JNK inhibitor SP600125 and the PI3K inhibitor wortmannin, respectively. Taken together, our results indicate that MCFAs, including octanoic acid, induced neurite outgrowth of PC12 cells in the absence of NGF and suggest that the activation of p38 MAPK and ERK pathways is involved in this process.

Metabolism/Metabolites · 4건

Various hypolipidemic agents differentially induced microsomal drug-metabolizing enzymes. Clofibrate, clofibric acid, fenofibric acid and dulofibrate, which are mainly hypotriglyceridemic, increased the content in cytochromes p450 (77-185% over control), and especially cytochrome p452-dependent lauric acid 12-hydroxylation (5.6 to 8.4-fold increase). Bilirubin glucuronidation was 2.1 to 2.8-fold stimulated; epoxide hydrolase activity (benzo(a)pyrene-oxide) was only slightly increased by the drugs. By contrast, F1379, which lowers plasma cholesterol only, did not change cytochromes p450 content and slightly affected the 12-hydroxylation of lauric acid. It dramatically enhanced the epoxide hydrolase activity (7.6-fold), and increased (200%) the glucuronidation of planar group I substrates (4-nitrophenol, 4-methylumbelliferone, 1-naphthol). These effects were accompanied by a highly positive staining of gamma-glutamyltransferase in the liver characterized by a great number of intensively colored foci in the periportal and perilobular area of the tissue. Treatment of rats for three weeks with F1379 did not modify this typical profile in enzyme induction. Such continuous effect could reveal some biochemical changes of hepatocytes with important toxicological relevance. Compared to the parent compound, treatment of rats with two metabolites of F1379 led to a decrease in the induction potency on epoxide hydrolase and on the forms of UDP-glucuronosyltransferase; by contrast, the content in cytochromes p450 was increased.

Omega-oxidation of fatty acids was assessed in rats. Aspirin increased liver free fatty acids and increased the capacity for omega-oxidation three to sevenfold. Omega-oxidation of long chain substrate was stimulated to a greater degree than medium chain substrate and was apparent within one day of treatment, at serum aspirin concentrations below the therapeutic range in humans. The apparent Km for lauric acid was 0.9 mM and 12 mM for palmitate. Ninety seven of the total laurate omega-oxidative activity recovered was found in the microsomes, but 32% of palmitate omega-oxidative activity was present in the cytosol. Aspirin is a potent stimulator of omega-oxidation. There may be multiple enzymes for omega-oxidation with overlapping substrate specificity.

... CYP6A8 was produced in Saccharomyces cerevisiae and enzymatically characterized after catalytic activity was reconstituted with D. melanogaster P450 reductase and NADPH. Although several saturated or non-saturated fatty acids were not metabolized by CYP6A8, lauric acid (C12:0), a short-chain unsaturated fatty acid, was oxidized by CYP6A8 to produce 11-hydroxylauric acid with an apparent V(max) of 25 nmol/min/nmol P450. This is the first report showing that a member of the CYP6 family catalyzes the hydroxylation of lauric acid. ...

Lauric acid has known human metabolites that include 12-Hydroxylauric acid.

Absorption, Distribution and Excretion · 3건

Fatty acids originating from adipose tissue stores are either bound to serum albumin or remain unesterified in the blood.

Oleic, palmitic, myristic, and stearic Acids are primarily transported via the lymphatic system, and lauric Acid is transported by the lymphatic and (as a free fatty acid) portal systems.

Proposed mechanisms for fatty acid uptake by different tissues range from passive diffusion to facilitated diffusion or a combination of both. Fatty acids taken up by the tissues can either be stored in the form of triglycerides (98% of which occurs in adipose tissue depots) or they can be oxidized for energy via the beta-oxidation and tricarboxylic acid cycle pathways of catabolism.

Tissue LocationsEpidermis
Cellular LocationsCytoplasm
Metabolite PathwaysAdrenoleukodystrophy, X-linked

용도 및 제조

Uses · 6건

CIR ingredient: Lauric Acid

This fatty acid is present in coconut oil and laurel oil. Used in alkyd resins, wetting agents, soaps, detergents, cosmetics, insecticides, and food additives; [Hawley]

Painting (Pigments, Binders, and Biocides) [Category: Paint]

Alkyd resins; wetting agents; soaps; detergents; cosmetics; insecticides; food additives.

Reported uses (ppm):

Plastics -> Typical concentration range in plastic materials -> 1%

U.S. Production · 3건

2023: 50,000,000 - <100,000,000 lb

Production volumes for non-confidential chemicals reported under the Inventory Update Rule. [Table#6310]

Dodecanoic acid is listed as a High Production Volume (HPV) chemical (65FR81686). Chemicals listed as HPV were produced in or imported into the U.S. in >1 million pounds in 1990 and/or 1994. The HPV list is based on the 1990 Inventory Update Rule. (IUR) (40 CFR part 710 subpart B; 51FR21438).

Consumer UsesCleaning agent
Industry UsesProcessing aids not otherwise specified
Methods of Manufacturing · 3건

Fractional distillation of mixed coconut or other acids.

Isolation from coconut oil; from arecanut fat; from Holoptelea integrifolia seed oil.

Produced from synthetic lauryl alcohol.

Formulations/PreparationsGrade: 99.8% pure, technical, Food Chemicals Codex
응용 분야 · 5건

용도명칭은 월계수의 학명에서 유래되었다. 세제 ·표 면활성제의 원료로 사용하는 라우릴알코올의 원료가 된다.

개요Lauric acid, also known as dodecanoic acid, is a saturated fatty acid with a 12-carbon atom chain, thus falling into the medium chain fatty acids, is a white crystalline carboxylic acid with a faint odor of bay oil or soap. It has been found at high levels in coconut oil. Lauric acid induces the activation of NF-κB and the expression of COX-2, inducible nitric oxide synthase (iNOS), and IL-1α in RAW 264.7 cells when used at a concentration of 25 μM.

출처Lauric acid, as a component of triglycerides, comprises about half of the fatty acid content in coconut oil, laurel oil, and in palm kernel oil (not to be confused with palm oil) , Otherwise it is relatively uncommon. It is also found in human breast milk ( 6.2 % of total fat), cow's milk (2.9%), and goat's milk (3.1 %).

용도Given its foaming properties, the derivatives of lauric acid (h-dodecanoic acid) are widely used as a base in the manufacture of soaps, detergents, and lauryl alcohol. Lauric acid is a common constituent of vegetable fats, especially coconut oil and laurel oil. It may have a synergistic effect in a formula to help fight against mircoorganisms. It is a mild irritant but not a sensitizer, and some sources cite it as comedogenic.

일반 설명White solid with a slight odor of bay oil.

제조 방법 · 1건

생산 방법Lauric acid is a fatty carboxylic acid isolated from vegetable and animal fats or oils. For example, coconut oil and palm kernel oil both contain high proportions of lauric acid. Isolation from natural fats and oils involves hydrolysis, separation of the fatty acids, hydrogenation to convert unsaturated fatty acids to saturated acids, and finally distillation of the specific fatty acid of interest.

추가 설명 · 3건

순도시험(1) 산가 : 이 품목 0.5g을 정밀히 달아 유지류시험법 중 산가에 따라 시험할 때, 252~287이어야 한다. (2) 응고점 : 이 품목의 응고점은 26.0~44.0℃이어야 한다. (3) 납 : 이 품목 5.0g을 취하여 원자흡광광도법 또는 유도결합플라즈마발광광도법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (4) 비소 : 이 품목을 비소시험법에 따라 시험할 때, 그 양은 4.0ppm 이하이어야 한다. (5) 수은 : 이 품목을 수은시험법에 따라 시험할 때, 그 양은 1.0ppm 이하이어야 한다. (6) 요오드가 : 이 품목 약 8.3g을 정밀히 달은 다음 미리 빙초산․시클로헥산의 혼액(1 : 1) 20mL 및 위이스시액 25mL를 넣어 둔 500mL 공전삼각플라스크에 가해주고 마개를 하고 격렬히 흔들어 준 다음 1시간 어두운 곳에 방치시킨 후 요오드칼륨시액 20mL, 끓여서 식힌 물 100mL를 가하여 과량의 요오드를 0.1N 치오황산나트륨용액으로 적정한다. 이때, 황색이 거의 없어질 때까지 계속 흔들어 주면서 일정하게 0.1N 치오황산나트륨용액을 적가한 다음 다시 전분시액을 가하여 청색이 완전히 없어질 때까지 적정을 계속한다. 종말점 가까이에서는 마개를 하여 격렬히 흔들어 준다. 따로 같은 방법으로 공시험을 행하고 다음 계산식에 따라 요오드가를 구할 때, 그 양은 3.0 이하이어야 한다.B : 공시험의 0.1N 치오황산나트륨용액의 소비량(mL)S : 본시험의 0.1N 치오황산나트륨용액의 소비량(mL (7) 검화가 : 이 품목 3g을 정밀히 달아 250mL 플라스크에 넣고 0.5N 알콜성수산화칼륨용액 50mL를 가한 액을 시험용액으로 하여 유지류시험법 중 검화가에 따라 시험하였을 때, 그 값은 253~287이어야 한다. (8) 불검화물 : 이 품목 5g을 정밀히 달아 250mL 플라스크에 취하고 수산화칼륨 2g 및 에탄올 40mL를 가해주고 환류냉각기를 부착한 다음 조용히 1시간 가열한다. 플라스크의 내용물을 40mL, 80mL, 130mL 눈금이 표시되어 있는 분액여두(길이 30cm, 직경 3.5cm)에 옮기고 플라스크는 충분한 양의 에탄올로 씻어 분액여두에 합하여 40mL로 하고, 다시 더운물과 찬물을 사용하여 플라스크를 씻어 옮겨주고 전량을 80mL로 한다. 마지막으로 석유에테르 수 mL로 플라스크를 씻어 분액여두에 옮겨주고 식힌 다음 석유에테르 50mL를 가해주고 실온이 되도록 내용물을 식힌 후 마개를 하고 최소한 1분간 격렬히 진탕한 후 방치하여 두 층으로 분리시킨다. 가능한 한 완전히 분리하고 상층액인 에테르층을 500mL 분액여두에 모은 다음 석유에테르 50mL씩으로 6번 추출한 후 추출액을 처음의 추출액과 합치고 이를 10% 에탄올 25mL로 씻어 주고 물층이 페놀프탈레인시액으로 정색하지 않을 때까지 이 조작을 반복한 후 물층을 완전히 제거한다. 에테르추출액은 미리 무게를 달아둔 비이커에 옮기고 에테르 10mL를 사용하여 분액여두를 씻은 다음 비이커에 합한다. 증기욕상에서 비이커의 에테르를 증발건고 한 다음 100℃에서 30분간 항량이 될 때까지 건조하고, 데시케이터내에서 방냉하여 잔류량을 평량한다. 이어서 잔류물을 미리 페놀프탈레인시액을 지시약으로 하여 수산화나트륨시액으로 중화시킨 따뜻한 알콜 50mL에 녹이고 0.02N 수산화나트륨용액으로 엷은 홍색이 지속될 때까지 적정하고 그 소비 mL수에 5.659(mg)를 곱하여 올레인산으로서의 양을 구하고 다음 계산식에 따라 불검화물 값을 구할 때, 그 양은 0.3% 이하이어야 한다.

정의이 품목은 코코넛오일 및 기타 식물성지방에서 얻어지는 고형지방산으로서 그 주성분은 라우린산(C12H24O2)이다.

정의ChEBI: Lauric acid is a straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil. It has a role as a plant metabolite, an antibacterial agent and an algal metabolite. It is a straight-chain saturated fatty acid and a medium-chain fatty acid. It is a conjugate acid of a dodecanoate. It derives from a hydride of a dodecane.

관련 반응

166건

연결된 노트

불러오는 중…